CRIS Current Research Information System

TADOLINI, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.279
NA - Nord America 4.122
EU - Europa 2.599
SA - Sud America 299
AF - Africa 281
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.596
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.055
SG - Singapore 1.253
CN - Cina 1.113
VN - Vietnam 937
GB - Regno Unito 802
SE - Svezia 388
DE - Germania 326
HK - Hong Kong 285
IT - Italia 269
BR - Brasile 214
KR - Corea 198
FR - Francia 189
IN - India 183
RU - Federazione Russa 173
IE - Irlanda 93
JP - Giappone 87
ZA - Sudafrica 81
FI - Finlandia 72
NL - Olanda 72
CI - Costa d'Avorio 68
SC - Seychelles 56
EE - Estonia 43
UA - Ucraina 40
AR - Argentina 39
ID - Indonesia 34
CA - Canada 32
TG - Togo 32
PH - Filippine 28
TW - Taiwan 24
CH - Svizzera 21
MX - Messico 21
AT - Austria 20
JO - Giordania 19
TH - Thailandia 17
BE - Belgio 16
IQ - Iraq 15
PK - Pakistan 15
BD - Bangladesh 14
BG - Bulgaria 14
PL - Polonia 14
EC - Ecuador 13
TR - Turchia 13
AU - Australia 12
GR - Grecia 10
MA - Marocco 8
NG - Nigeria 8
CL - Cile 7
ES - Italia 7
MY - Malesia 7
CO - Colombia 6
ET - Etiopia 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
DZ - Algeria 5
LT - Lituania 5
PY - Paraguay 5
VE - Venezuela 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
PE - Perù 4
RO - Romania 4
AL - Albania 3
AZ - Azerbaigian 3
EG - Egitto 3
IL - Israele 3
IR - Iran 3
KE - Kenya 3
LB - Libano 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CY - Cipro 2
CZ - Repubblica Ceca 2
EU - Europa 2
LS - Lesotho 2
MD - Moldavia 2
MM - Myanmar 2
PT - Portogallo 2
SI - Slovenia 2
TN - Tunisia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BZ - Belize 1
CD - Congo 1
CG - Congo 1
CM - Camerun 1
GH - Ghana 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
Totale 11.588
Salva come PNG Salva come JPEG
Città #
Singapore 860
Southend 745
Ashburn 499
Fairfield 379
Hefei 377
Santa Clara 306
Hong Kong 275
Ho Chi Minh City 251
Chandler 208
Hanoi 206
Wilmington 186
Seoul 185
Houston 181
Woodbridge 177
Seattle 171
San Jose 166
Cambridge 147
Beijing 130
Princeton 128
Ann Arbor 117
Boardman 100
Dallas 97
Dublin 93
Dong Ket 88
Lauterbourg 81
Tokyo 79
Bologna 71
Abidjan 68
New York 63
Nanjing 56
Helsinki 55
Council Bluffs 53
Los Angeles 52
Frankfurt am Main 50
Westminster 46
Buffalo 42
Bengaluru 40
Padova 40
Dearborn 35
Lomé 32
San Diego 32
Saint Petersburg 30
Haiphong 29
Johannesburg 29
Berlin 28
Milan 28
Nuremberg 26
Redondo Beach 26
Da Nang 24
The Dalles 23
Jakarta 22
São Paulo 20
Bern 19
Amman 18
Des Moines 16
Nanchang 16
Brussels 15
Falls Church 15
Amsterdam 14
Hebei 14
Sofia 14
Tongling 14
Toronto 14
Changsha 13
Falkenstein 13
Guangzhou 13
Hải Dương 13
Jinan 13
Shanghai 13
Shenyang 13
Yubileyny 13
Bremen 12
Bangkok 11
Lappeenranta 11
Moscow 11
Munich 11
Redwood City 11
Tianjin 11
Zhengzhou 11
Biên Hòa 10
London 10
Washington 10
Atlanta 9
Can Tho 9
Chennai 9
Warsaw 9
Chengdu 8
Chicago 8
Jiaxing 8
Phoenix 8
Quận Bình Thạnh 8
Redmond 8
San Francisco 8
Vienna 8
Campinas 7
Denver 7
Harbin 7
Jacksonville 7
Kunming 7
Montreal 7
Totale 7.786
Salva come PNG Salva come JPEG
Nome #
Trend of microbiologically-confirmed tuberculosis in a low-incidence setting with high immigration rates 404
Spinal tuberculosis: Proposed spinal infection multidisciplinary management project (SIMP) flow chart revision 246
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 244
First evaluation of QuantiFERON-TB gold plus performance in contact screening 194
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy 183
Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF 182
IGRA test for TB in COVID-19: role of corticosteroids 180
TB consilia and quality of tuberculosis management 178
Evaluation of trace calls by Xpert MTB/RIF ultra for clinical management in low TB burden settings 175
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment 173
Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review 170
Clinical impact of reninangiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for coronavirus disease 2019 169
A new free-cost e-service supporting clinicians to manage their difficult-to-treat tuberculosis cases: The European respiratory society-World Health Organization tuberculosis consilium 168
Effectiveness and safety of meropenem/ clavulanate-containing regimens in the treatment of MDR- and XDR-TB 165
Multidetector CT urography in urogenital tuberculosis: use of reformatted images for the assessment of the radiological findings. A pictorial essay 165
A multidrug resistant tuberculosis case treated with continuous infusion of meropenem in outpatient care 165
Tuberculosis elimination: Theory and practice in Europe 160
Overview of fever of unknown origin in adult and paediatric patients 159
Combined use of delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis: A systematic review 158
Comparison of effectiveness and safety of imipenem/clavulanate-versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB 156
Predictors of time to sputum smear conversion in patients with pulmonary tuberculosis under treatment 156
Active tuberculosis, sequelae and COVID-19 co-infection: First cohort of 49 cases 156
Membranoproliferative glomerulonephritis associated with human immunodeficiency virus, hepatitis B and hepatitis C virus coinfection: case report and literature review. 155
The International Journal of Tuberculosis and Lung Disease (IJTLD) 154
Crossborder travel and multidrugresistant tuberculosis (MDRTB) in Europe 154
Update of drug-resistant tuberculosis treatment guidelines: A turning point 153
Systematic Tuberculosis Screening in Asylum Seekers in Italy 151
World Tuberculosis Day 2023 theme “Yes! We Can End TB!” 149
Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: Early experiences and challenges 149
Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study 148
Clinical standards for drug-susceptible pulmonary TB 148
Clinical standards for the management of adverse effects during treatment for TB 147
Challenging MDR-TB clinical problems – The case for a new Global TB Consilium supporting the compassionate use of new anti-TB drugs 146
Clinical standards for the dosing and management of TB drugs 145
Policy and programmatic directions for the Lesotho tuberculosis programme: Findings of the national tuberculosis prevalence survey, 2019 144
The first population-based national tuberculosis prevalence survey in Ethiopia, 2010-2011 144
Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy 142
Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis 141
Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine 141
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort 140
First independent evaluation of QuantiFERON-TB Plus performance 140
Combining bedaquiline and delamanid to treat multidrug-resistant tuberculosis 139
Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: A systematic review 136
Compassionate and optimum use of new tuberculosis drugs 135
Quantiferon-TB performs better in children, including infants, than in adults with active tuberculosis: a multicentre study 134
How We Treat Drug-Susceptible Pulmonary Tuberculosis: A Practical Guide for Clinicians 133
Seventeen cases of Mycobacterium marinum infection in Italy: A multicenter retrospective study 130
Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine 129
Recommendations for the diagnosis of pediatric tuberculosis 129
Vaccination in post-tuberculosis lung disease management: A review of the evidence 128
Healthcare seeking patterns for TB symptoms: Findings from the first national TB prevalence survey of South Africa, 2017–2019 127
Do we need a new Fleming époque: The nightmare of drug-resistant tuberculosis 126
New and repurposed drugs for pediatric multidrug-resistant tuberculosis practice-based recommendations 126
Human herpesvirus-8-related Kaposi’s sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin. 125
Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017-19: a multistage, cluster-based, cross-sectional survey 124
Recommendations for treating children with drug-resistant tuberculosis 123
Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): A study protocol of a prospective multicentre cohort study 123
First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline 121
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort 120
Paediatric tuberculosis in Europe: Lessons from Denmark and inclusive strategies to consider 118
ERS/WHO Tuberculosis Consilium: Reporting of the initial 10 cases 116
Supporting clinical management of the difficult-to-treat TB cases: The ERS-WHO TB Consilium 116
Recommendations Concerning the Therapeutic Approach to Immunocompromised Children with Tuberculosis 114
Faster for less: The new "shorter" regimen for multidrug-resistant tuberculosis 114
WHO strategies for the programmatic management of drug-resistant tuberculosis 113
ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: Case study of compassionate delamanid use 112
Recommendations Concerning the First-Line Treatment of Children with Tuberculosis 111
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts 105
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: First global report 98
Introduction of bedaquiline for the treatment of multi-drug resistant tuberculosis at country level: implementation plan 97
Comprehensive Whole Genome Sequencing Dataset of Mycobacterium tuberculosis Strains Collected Across Italy 96
On tuberculosis and COVID-19 co-infection 95
National population-based tuberculosis prevalence survey in Ghana, 2013 90
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020 87
TB mortality in low-incidence countries: can we reduce it further? 86
National tuberculosis prevalence surveys in Africa, 2008–2016: an overview of results and lessons learned 81
A new free-cost e-service supporting clinicians to manage their difficult-to-treat TB cases: The ERS-WHO TB consilium 77
Gauging the impact of the COVID-19 pandemic on tuberculosis services: A global study 73
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study 72
Reducing tuberculosis transmission: A consensus document from the World Health Organization Regional Office for Europe 71
High TB burden and low notification rates in the Philippines: The 2016 national TB prevalence survey 65
COVID-19 Hampered Diagnosis of TB Infection in France, Italy, Spain and the United Kingdom 64
null 64
TB outpatient care in a high-income, low-incidence country 58
We cannot eliminate TB without TB drugs: a wake-up call from Italy 57
null 57
Ten common myths about drug-susceptible TB 50
National TB prevalence surveys in the COVID-19 era 50
Efficacy, safety, and tolerability of a 24-month treatment regimen including delamanid in a child with extensively drug-resistant tuberculosis: A case report and review of the literature 47
Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond 45
Consolidated guidance on tuberculosis data generation and use. Module 3. National tuberculosis prevalence surveys. Geneva: World Health Organization; 2025. Licence: CC BY-NC-SA 3.0 IGO 39
Post-tuberculosis lung disease: a guide for clinicians 9
Impact of the COVID-19 pandemic on tuberculosis services in a rural area of Senegal 8
Totale 11.860
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.785
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.785
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021317 0 0 0 0 0 0 0 0 0 58 42 217
2021/20221.145 69 72 79 116 109 54 28 79 30 101 210 198
2022/20231.111 84 134 66 137 104 100 42 63 234 19 77 51
2023/2024470 30 62 37 50 53 108 14 21 31 36 16 12
2024/20252.082 36 272 122 120 407 119 131 60 23 109 143 540
2025/20264.281 474 589 557 375 498 275 406 136 712 259 0 0
Totale 11.860